December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

121.47 -2.81 (-2.26%)
Streaming Delayed Price Updated: 10:05 AM EDT, Mar 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
36 37 Next >
News headline image
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo... 
Via Benzinga
News headline image
Why Are Illumina Shares Trading Higher Today? ↗
At the J.P. Morgan Healthcare Conference, Illumina Inc (NASDAQ: ILMN) said it expects about $4.517 billion, +39% Y/Y in 2021 revenue after the company logged... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
Keybanc cut the price target for Netflix, Inc. (NASDAQ: 
Via Benzinga
News headline image
21 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from... 
Via Benzinga
News headline image
Early Cancer Detection for Dogs Is Here
SOURCE: Illumina 
Via 3BL Media
News headline image
Illumina Selected As a Best Place to Work in Biopharma
SOURCE: Illumina 
Via 3BL Media
News headline image
A Peek Into The Markets: US Stock Futures Higher Ahead Of Powell ↗
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones dipped more than 160 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
News headline image
5 Stocks To Watch For January 11, 2022 ↗
Some of the stocks that may grab investor focus today are: Wall Street expects TD SYNNEX Corporation (NYSE: SNX) to report quarterly earnings at $2.67 per share on revenue of $... 
Via Benzinga
News headline image
Start Of The Week ↗
British property (real estate) stocks fell today. 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Inari Medical (NASDAQ:NARI) stock... 
Via Benzinga
News headline image
Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care
From Agendia, Inc.
Via Business Wire
News headline image
Knight Cancer Institute at Oregon Health & Science University to Offer the Galleri® Multi-Cancer Early Detection Test
From GRAIL, LLC
Via Business Wire
News headline image
GRAIL and Premier’s PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test
From GRAIL, LLC
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 ↗
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE: 
Via Benzinga
News headline image
Illumina Donates Over $14 Million to Local Communities and Volunteers More Than 6,000 Hours in 2021
SOURCE: Illumina 
Via 3BL Media
News headline image
Why Jim Cramer Likes Illumina And Enterprise Products Partners ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating... 
Via Benzinga
News headline image
Illumina Enters Co-Development Partnership with SomaLogic to Help Researchers’ Understanding of Biology and Disease
SOURCE: Illumina 
Via 3BL Media
News headline image
Illumina CEO Reflects on the State of Genomics in 2021
SOURCE: Illumina 
Via 3BL Media
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
News headline image
Illumina Supports Norway's Pioneering Precision Medicine Study
SOURCE: Illumina 
Via 3BL Media
News headline image
Gretel and Illumina Partner to Develop Synthetic Data for Genomic Research
From Gretel
Via Business Wire
News headline image
Amid Pandemic, Illumina Invests in 'Culture of Care'
SOURCE: Illumina 
Via 3BL Media
Topics Supply Chain
News headline image
Why Jim Cramer Likes Illumina, SoFi And More ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said SoFi Technologies, Inc’s (NASDAQ: 
Via Benzinga
News headline image
GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri® Multi-Cancer Early Detection Blood Test
From GRAIL, LLC
Via Business Wire
News headline image
Illumina Ranked #2 on Newsweek's America's Most Responsible Companies 2022 List
SOURCE: Illumina 
Via 3BL Media
News headline image
Illumina and Sequoia Capital China Select First Startups to Join Genomics Incubator in China
SOURCE: Illumina 
Via 3BL Media
News headline image
Bionano Genomics Proves Not Everything Genetic is Gold ↗
Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes. 
Via InvestorPlace
News headline image
10x Genomics Stock: Bull vs. Bear ↗
After a hot start, the stock has recently lagged the market. Is now a good time to buy? 
Via The Motley Fool
Topics Initial Public Offering
News headline image
Wait for Bionano Stock to Fall Further Before Buying ↗
BNGO stock is breaking down following the latest earnings report, and there are no major catalysts to push shares up in the short term. 
Via InvestorPlace
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.